BR100 Decreased By (-0.04%)
BR30 Increased By (0.22%)
KSE100 Decreased By (-0.11%)
KSE30 Decreased By (-0.2%)
AGHA 7.59 Decreased By ▼ -0.04 (-0.52%)
BECO 5.12 Decreased By ▼ -0.45 (-8.08%)
BML 59.15 Decreased By ▼ -0.59 (-0.99%)
BOP 34.79 Increased By ▲ 0.39 (1.13%)
CNERGY 13.69 Increased By ▲ 0.58 (4.42%)
CSIL 6.33 Decreased By ▼ -0.08 (-1.25%)
FCCL 57.58 Decreased By ▼ -0.48 (-0.83%)
FFL 16.54 Increased By ▲ 0.31 (1.91%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.32 Decreased By ▼ -0.11 (-1.48%)
KOSM 6.00 Decreased By ▼ -0.03 (-0.5%)
LOTCHEM 27.50 Decreased By ▼ -0.17 (-0.61%)
MLCF 101.90 Decreased By ▼ -0.85 (-0.83%)
NBP 203.86 Decreased By ▼ -1.20 (-0.59%)
NCPL 60.66 Increased By ▲ 1.03 (1.73%)
NPL 70.00 Increased By ▲ 1.44 (2.1%)
OGDC 318.80 Decreased By ▼ -0.12 (-0.04%)
PACE 11.09 Increased By ▲ 0.04 (0.36%)
PAEL 43.07 Decreased By ▼ -0.03 (-0.07%)
PIBTL 16.75 Increased By ▲ 0.12 (0.72%)
PPL 231.37 Increased By ▲ 1.92 (0.84%)
PRL 77.16 Increased By ▲ 6.36 (8.98%)
PTC 71.00 No Change ▼ 0.00 (0%)
SSGC 27.23 Decreased By ▼ -0.18 (-0.66%)
TBL 10.25 Decreased By ▼ -0.06 (-0.58%)
TELE 8.61 Increased By ▲ 0.08 (0.94%)
TPL 23.62 Increased By ▲ 0.56 (2.43%)
TPLP 15.30 Decreased By ▼ -0.46 (-2.92%)
TREET 24.58 Decreased By ▼ -0.13 (-0.53%)
TRG 60.00 Decreased By ▼ -0.29 (-0.48%)

Brazil on Friday announced a ban on French-made breast implants at the center of an international furor over their potential rupture risks. The National Agency for Sanitary Surveillance (ANVISA) withdrew its health authorisation for the implants, the sale of which had already been suspended since 2010.
Between 300,000 and 400,000 women in 65 countries from Europe to Latin America have implants made with sub-standard silicone gel by 72-year-old Jean-Claude Mas's now-bankrupt company Poly Implant Prothese (PIP). ANVISA reached its decision after France last week advised 30,000 women to have their PIP implants removed because of an increased risk of rupture. Brazil had imported 34,631 of the implants, including 24,534 which were sold before the 2010 suspension. ANVISA advised women to consult with their doctors over the risks of the implants.

Copyright Agence France-Presse, 2011

Comments

Comments are closed for this article.